BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp® (NYSE: LH), a leading global life sciences company, today announced a new collaboration with HealthVerity, Inc., the ...

Already a monolith in the clinical testing space, Labcorp is aiming to further swell its testing capabilities with the acquisition of contract research organization Toxikon. The CRO provides ...

LabCorp reported net revenues of nearly $9.5 billion for 2016 through the contributions of 52,000 employees in approximately 60 countries. To learn more about LabCorp, visit www.labcorp.com, and to ...

The yet-to-be-named new company will be publicly traded. Separating the laboratory testing work of LabCorp from the clinical trial services business, much of which came from acquisitions, will enable ...

Innovative collaboration advances the development of novel gene therapies for patients by providing coordinated services across Forge’s leading AAV manufacturing capabilities and Labcorp’s scientific ...

(Reuters) - Laboratory Corp of America Holdings missed estimates for quarterly profit on Tuesday, as its drug development unit struggled against curbs on animal imports, while a sharp fall in sales of ...

Laboratory Corporation of America Holdings LH or LabCorp recently partnered with Community Clinical Oncology Research Network, LLC (CCORN) to better understand the impact of disparities in precision ...

BURLINGTON – Labcorp on Thursday reported a third-quarter profit of $352.8 million yet its overall financials didn’t meet Wall Street expectations. But CEO Adam Schechter said the company “made ...

July 28 (Reuters) - Diagnostics company Labcorp plans to spin off its unit focused on clinical drug trials, the Wall Street Journal reported on Thursday, citing people familiar with the matter.

The positions in the table below reflect the Labcorp Drug Development's position overall, domestically, within their sector, and in various subject areas based on their Share. Each position links to ...